Acetaldehyde adducts of proteins: Diagnostic and pathogenic implications in diseases caused by excessive alcohol consumption
- 1 January 1993
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 53 (sup213) , 45-54
- https://doi.org/10.3109/00365519309090673
Abstract
Alcohol abuse and alcoholism continue to be a major threat to human health. Given their increasing incidence and the detrimental impact on society, it is actually surprising that no objective, specific indicators for the early detection of alcohol-related health problems are available. A diagnostic test for a disease involving excessive alcohol consumption should be extremely specific in order to achieve positive predictive power, and: ideally it should also be very sensitive in order to identify problem drinkers in broad screening programs. The present research indicates that such a test for alcohol abuse may be provided by measurements of covalent chemical addition products (adducts) of acetaldehyde with biologically stable macromolecules. It was recently demonstrated that proteins modified with acetaldehyde are formed in vivo and can induce an antibody response as a result of alcohol consumption. Monoclonal and polyclonal antibodies raised by immunizations against acetaldehyde-modified proteins recognize acetaldehyde adducts irrespective of the nature of the carrier protein. Use of such antibodies in sensitive two-site immunoenzymatic or immunofluorometric assays has indicated that high acetaldehyde adduct concentrations exist in the erythrocytes of alcohol abusers, in healthy volunteers after a bout of drinking, and also in alcohol consuming mothers who subsequently give birth to children with foetal alcohol effects. We have developed the first immunohistochemical techniques for the detection of acetaldehyde adducts in human tissues. The centrilobular region of the liver of alcohol abusers with an early stage of histological tissue damage was found to contain acetaldehyde-modified epitopes, whereas the adducts were more widespread in advanced liver disease. The diagnostic superiority of acetaldehyde adducts as markers of ethanol consumption is due to the fact that they represent true metabolites of ethanol and allow estimations of past alcohol consumption after the ethanol has been eliminated from the body. Investigations into the formation of acetaldehyde adducts in alcohol consumers do not only have diagnostic applications but also help to explain the pathogenesis of alcohol-induced organ damage. Many types of hypersensitivity and immune responses are brought about by acetaldehyde-modified proteins. In addition, such metabolites of ethanol also aggravate liver disease through disturbed protein function and stimulation of fibrogenesis.Keywords
This publication has 20 references indexed in Scilit:
- Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.Journal of Clinical Investigation, 1991
- Further Studies on the 37 Kd Liver Protein–Acetaldehyde Adduct That Forms In Vivo During Chronic Alcohol IngestionHepatology, 1989
- Acetaldehyde substoichiometrically inhibits bovine neurotubulin polymerization.Journal of Clinical Investigation, 1989
- Covalent binding of acetaldehyde to type III collagenBiochemical and Biophysical Research Communications, 1989
- Biochemical and Molecular Basis of Alcohol-Induced Injury to Liver and Other TissuesNew England Journal of Medicine, 1988
- Detection of a protein-acetaldehyde adduct in the liver of rats fed alcohol chronically.Journal of Clinical Investigation, 1988
- The Functional Implications of Acetaldehyde Binding to Cell ConstituentsaAnnals of the New York Academy of Sciences, 1987
- Red blood cells: A new major modality for acetaldehyde transport from liver to other tissuesLife Sciences, 1987
- Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts.Proceedings of the National Academy of Sciences, 1986
- Acetaldehyde adducts with hemoglobin.Journal of Clinical Investigation, 1981